About RiboTargets
RiboTargets is a company based in Abington (United States) founded in 1997 was acquired by Vernalis in October 2003. RiboTargets offers products and services including Identity Theft Resources and Blog Content. RiboTargets operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Abington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RiboTargets
RiboTargets offers a comprehensive portfolio of products and services, including Identity Theft Resources and Blog Content.
Provides articles and tips on preventing identity theft
Delivers posts on security and miscellaneous topics
Funding Insights of RiboTargets
Detailed funding history for RiboTargets
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in RiboTargets
RiboTargets has secured backing from 1 investor. Prominent investors backing the company include Vernalis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Vernalis is engaged in structure-based drug discovery collaborations.
|
Locked | Locked | Locked |
Investor details for RiboTargets
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RiboTargets
Investment portfolio details for RiboTargets
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RiboTargets
Detailed financials for RiboTargets
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ribotargets Comparisons
Peer comparison for RiboTargets
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RiboTargets
RiboTargets operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Developer of biologics to treat hepatitis B infection
|
|
| Locked | Locked | Locked |
Developer of computationally designed VLP vaccines for treating multiple infections
|
Detailed competitors of RiboTargets
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ribotargets
Complete news archive for RiboTargets
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RiboTargets
RiboTargets was founded in 1997.
RiboTargets is headquartered in Abington, United States. It is registered at Abington, Massachusetts, United States.
As of April 23, 2003, RiboTargets Holdings plc was acquired by British Biotech plc. RiboTargets Holdings plc, a biotechnology company, engages in the discovery and development of small molecule therapeutics addressing areas of medical need in infection and cancer treatment. Its research and development is focused on protein targets for new cancer therapies and anti-infective therapies. RiboTargets technology is focused on the interactions between RNA and its regulatory proteins, such as those that attach ribosomes before translation, or move RNA around the cell. The company also has developed three-dimensional computer simulations of RNA binding sites to find small molecules with the correct structure to be specific.
RiboTargets's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
RiboTargets offers Identity Theft Resources and Blog Content.
RiboTargets has 1 investor. Key investors include Vernalis.